BSL — Bhayani Securities (Pvt) Ltd.
EFERT logo

Rs 209.20 ▼ -1.68 (-0.80%)As of 13:15

View EFERT share price

Engro Fertilizers Limited: Presentation of Corporate Briefing Session Q3 2026

Corporate BriefingCAUTIOUSLY POSITIVE

Key facts

Date
23rd October 2026
Market Share
EFERT gained 38% in the Urea market despite premium pricing, driven by strategic planning and supply chain execution.
Challenges
Rising input costs due to global supply disruptions impacted affordability for farmers, particularly for DAP fertilizers.
Future Outlook
Positive crop economics and government support prices are expected to sustain farmer confidence and fertilizer demand.
CAPEX Update
Approximately USD 300M investment in the Pressure Enhancement Facility to secure long-term operations, with completion expected by Q1 2027.

What this means: This is an informational session on 23rd October 2026 for shareholders and analysts — it does not itself require any action from you.

Engro Fertilizers Limited held a Corporate Briefing for Q3 2026, discussing its performance, market conditions, and future outlook amidst ongoing economic challenges.

  • Session Date: 23rd October 2026
  • Key Highlights:
  • Revenue for Q3 2026 reached PKR 79.6 Bn, up 45% YoY.
  • Net Profit increased to PKR 9.1 Bn, a 57% rise compared to the previous year.
  • EPS improved to PKR 6.83 from PKR 4.35 in Q3 2025.
  • Market Share: EFERT gained 38% in the Urea market despite premium pricing, driven by strategic planning and supply chain execution.
  • Challenges: Rising input costs due to global supply disruptions impacted affordability for farmers, particularly for DAP fertilizers.
  • Future Outlook: Positive crop economics and government support prices are expected to sustain farmer confidence and fertilizer demand.
  • CAPEX Update: Approximately USD 300M investment in the Pressure Enhancement Facility to secure long-term operations, with completion expected by Q1 2027.

About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange, per our editorial policy and data methodology. A summary for information, not investment advice — the original filing is the authoritative record.

Trade EFERT with BSL

Act on this filing with live PSX data, research support, and a broker built for it.

Open an account